Why Inspire (INSP) Might be Well Poised for a Surge

Core Viewpoint - Inspire Medical Systems (INSP) shows potential as a strong investment opportunity due to significant revisions in earnings estimates, indicating an improving earnings outlook [1][2] Current-Quarter Estimate Revisions - The earnings estimate for the current quarter is $0.07 per share, reflecting a year-over-year increase of +124.14% [4] - In the last 30 days, five estimates have been revised upward while two have been revised downward, leading to a Zacks Consensus Estimate increase of 612.5% [4] Current-Year Estimate Revisions - The expected earnings for the full year are $0.63 per share, representing a +187.5% change from the previous year [5] - Over the past month, seven estimates have been revised upward with no negative revisions, resulting in a consensus estimate increase of 381.02% [5] Favorable Zacks Rank - The positive estimate revisions have earned Inspire a Zacks Rank 1 (Strong Buy), indicating strong potential for outperformance [6] - Research indicates that stocks with Zacks Rank 1 and 2 significantly outperform the S&P 500 [6] Bottom Line - The stock has gained 38.4% over the past four weeks, driven by solid estimate revisions, suggesting that it may be a good addition to investment portfolios [7]